https://annualreport2019.vhir.org/highlight/the-michael-j-fox-foundation-will-finance-a-research-project-on-new-drugs-for-parkinsons-disease/2020-08-05T08:48:46+00:00https://annualreport2019.vhir.org/highlight/the-mimark-project-selected-to-participate-in-the-health-horizons-conference/2020-08-05T08:51:08+00:00https://annualreport2019.vhir.org/highlight/the-vhir-has-two-phd-students-with-the-inphinit-scholarship-from-the-obra-social-of-la-caixa/2020-08-05T08:52:07+00:00https://annualreport2019.vhir.org/highlight/dra-anna-m-meseguer-awarded-by-the-college-of-biologists-of-catalonia/2020-08-05T08:54:43+00:00https://annualreport2019.vhir.org/highlight/msd-rewards-the-consultation-project-to-detect-comorbidities-in-patients-over-50-with-hiv-aids/2020-08-05T08:54:22+00:00https://annualreport2019.vhir.org/highlight/vhir-participates-in-the-safe-n-medtech-project-for-recycling-sanitary-devices/2020-08-05T08:55:51+00:00https://annualreport2019.vhir.org/highlight/vhir-obtains-eight-peris-grants-for-an-amount-of-more-than-one-million-euros/2020-08-06T08:28:15+00:00https://annualreport2019.vhir.org/highlight/the-future-of-research-gives-a-greater-role-to-patients/2020-08-05T08:58:48+00:00https://annualreport2019.vhir.org/highlight/la-caixa-foundation-gives-vall-dhebron-the-first-radiological-robot-in-the-world-to-be-used-in-an-endoscopy-service/2020-09-07T10:10:40+00:00https://annualreport2019.vhir.org/highlight/ariadna-laguna-obtains-the-junior-leader-retaining-grant-by-la-caixa-foundation/2020-08-05T09:50:07+00:00https://annualreport2019.vhir.org/highlight/vall-dhebron-will-coordinate-three-horizon-2020-european-projects/2020-08-05T09:51:33+00:00https://annualreport2019.vhir.org/highlight/vall-dhebron-and-la-caixa-foundation-present-a-pioneering-space-to-study-the-brains-of-migraine-patients-the-migraine-adaptive-brain-center/2020-08-05T09:57:23+00:00https://annualreport2019.vhir.org/highlight/modis-therapeutics-a-startup-with-vhir-licensed-technology-is-acquired-by-zogenix-for-250m/2020-08-05T09:59:17+00:00https://annualreport2019.vhir.org/highlight/vhir-participates-in-the-immune-image-project-to-develop-new-diagnostic-diagnoses-to-detect-the-dynamics-of-immunological-cells-in-vivo-with-pet-ct/2020-08-05T11:48:20+00:00https://annualreport2019.vhir.org/highlight/vhir-receives-almost-e-700-000e-from-la-marato-2018-for-two-research-projects-in-pediatric-oncology/2020-08-05T12:14:36+00:00https://annualreport2019.vhir.org/highlight/two-vhir-researchers-awarded-a-gilead-scholarship/2020-08-05T17:14:02+00:00https://annualreport2019.vhir.org/highlight/four-professionals-and-a-medical-team-from-vall-dhebron-receive-the-comb-professional-excellence-awards/2020-08-05T17:18:29+00:00https://annualreport2019.vhir.org/highlight/the-government-distinguishes-dr-josep-ordi-with-a-josep-trueta-medal-for-health-merit/2020-08-06T08:33:58+00:00https://annualreport2019.vhir.org/highlight/green-light-to-iriscat-the-alliance-of-research-and-innovation-centers-in-health-in-catalonia-in-which-vhir-participates/2020-08-05T17:22:24+00:00https://annualreport2019.vhir.org/highlight/vall-dhebron-and-janssen-lead-the-eu-pearl-project-that-will-define-the-future-of-clinical-trials-in-europe/2020-08-06T08:37:38+00:00https://annualreport2019.vhir.org/highlight/genetic-predisposition-favors-cannabis-use-in-people-with-adhd/2020-08-05T17:33:23+00:00https://annualreport2019.vhir.org/highlight/vall-dhebron-leads-the-first-international-vaccination-guide-for-human-papilloma-virus-in-high-risk-populations/2020-08-06T08:47:48+00:00https://annualreport2019.vhir.org/highlight/established-that-the-excessive-accumulation-of-brain-neuromelanin-cause-the-parkinsons-disease/2020-08-05T17:56:18+00:00https://annualreport2019.vhir.org/highlight/demonstrate-for-the-first-time-in-humans-that-the-application-of-neuroprotective-eye-drops-is-useful-in-the-treatment-of-diabetic-retinopathy/2020-08-05T17:59:26+00:00https://annualreport2019.vhir.org/highlight/researchers-at-vhir-identify-a-new-therapeutic-tool-based-on-micrornas-against-a-type-of-childhood-cancer/2020-08-05T18:05:26+00:00https://annualreport2019.vhir.org/highlight/researchers-of-vhir-and-irblleida-validate-the-new-antitumor-agent-abtl0812-as-a-new-therapeutic-strategy-to-fight-against-endometrial-cancer/2020-08-05T18:24:02+00:00https://annualreport2019.vhir.org/highlight/can-diesel-particles-cause-asthma-in-healthy-people/2020-09-03T10:48:06+00:00https://annualreport2019.vhir.org/highlight/discovered-that-the-inhibition-of-calpains-limits-hypertrophy-and-myocardial-remodeling/2020-09-03T10:48:42+00:00https://annualreport2019.vhir.org/highlight/a-study-indicates-a-new-route-of-amplification-and-dissemination-of-hiv-infection-in-women-through-immune-cells-of-the-cervix/2020-08-05T18:44:56+00:00https://annualreport2019.vhir.org/highlight/evobrutinib-quickly-reduces-brain-injuries-in-recurrent-multiple-sclerosis/2020-08-05T18:57:10+00:00https://annualreport2019.vhir.org/highlight/a-study-shows-that-there-are-no-significant-differences-between-non-invasive-ventilation-and-continuous-positive-pressure-of-the-airways-in-the-hypoventilation-syndrome-due-to-obesity/2020-08-05T18:58:34+00:00https://annualreport2019.vhir.org/highlight/new-nucleoside-therapy-improves-motor-function-and-survival-of-patients-with-tk2-deficiency/2020-09-07T15:04:53+00:00https://annualreport2019.vhir.org/highlight/discovered-one-of-the-possible-causes-of-autoimmune-diseases/2020-09-07T15:05:40+00:00https://annualreport2019.vhir.org/highlight/new-test-for-the-diagnosis-of-viral-and-bacterial-infections/2020-08-05T19:02:56+00:00https://annualreport2019.vhir.org/highlight/vall-dhebron-takes-an-important-step-to-eliminate-the-cellular-reservoir-of-hiv/2020-08-05T19:04:16+00:00https://annualreport2019.vhir.org/highlight/a-gene-therapy-clinical-trial-for-patients-with-fanconi-anemia-offers-first-successful-results/2020-08-05T19:06:10+00:00https://annualreport2019.vhir.org/highlight/vall-dhebron-identifies-a-new-cell-type-as-the-main-target-and-reservoir-in-the-tissues-of-people-infected-with-hiv/2020-08-05T19:07:03+00:00https://annualreport2019.vhir.org/highlight/new-paths-for-therapeutic-strategies-aimed-at-reducing-reperfusion-injury-after-a-heart-attack/2020-09-04T07:37:13+00:00https://annualreport2019.vhir.org/highlight/rivaroxaban-would-almost-double-the-risk-of-recurrent-thrombosis-in-patients-with-antifosfolipid-antibody-syndrome-compared-with-warfarin/2020-08-05T19:09:05+00:00https://annualreport2019.vhir.org/highlight/a-single-fecal-microbial-transplant-can-modulate-the-microbiome-and-improve-the-clinical-manifestations-of-colitis-in-an-animal-model/2020-08-05T19:10:30+00:00https://annualreport2019.vhir.org/highlight/managing-zileuton-by-means-of-polymeric-micelles-significantly-reduces-the-tumor-stem-cells-of-breast-cancer-within-the-tumor-and-in-the-bloodstream/2020-08-05T19:11:11+00:00https://annualreport2019.vhir.org/highlight/discovered-the-transcendental-role-of-gut-microbiota-in-the-development-of-alcoholic-hepatitis/2020-08-05T19:12:28+00:00https://annualreport2019.vhir.org/highlight/identifed-a-key-protein-in-cardiac-healing-and-remodeling-after-pressure-overload/2020-08-05T19:15:16+00:00